US 2012/0071339 A1Published application

Biomarkers

AssigneePsynova Neurotech Ltd.

InventorsSabine Bahn, Emanuel Schwarz

Life of this patent

Estimating the term…

The invention relates to a method of diagnosing or monitoring multiple sclerosis.

Dependent claims

Use of one or more first peptides selected from:

GRO alpha, HB EGF, Tetanus Toxoid, Lipoprotein a and Adiponectin as a biomarker for multiple sclerosis, or predisposition thereto.

Dependencies are inferred from the claim text.

G01N 33/564
Immunoassay; Biospecific binding assay; Materials therefor: for pre-existing immune complex or autoimmune disease , i.e. systemic lupus…
G01N 2800/285
Neurological disorders: demyelinating diseases; Multipel sclerosis
G01N 2800/52
Detection or diagnosis of diseases: predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in…
G01N 2800/60
Detection or diagnosis of diseases: complex ways of combining multiple protein biomarkers for diagnosis

No related US applications are recorded in the indexed filing history.

Loading patent…